Priority Date: 13.02.12 (EP 20120382048)

USE OF THE SOLUBLE FORM OF AXL IN THE DIAGNOSIS AND/OR PROGNOSIS OF HEART FAILURE SYNDROME

  • Application ID: EP13703603
  • Status: PATENT GRANTED

Attorneys

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing
Employment test 11 - 50 employees
Company dna zbm patents sl
no operation time available
Headquarter in Barcelona and 2 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This patent has the IPC class G01 (MEASURING; TESTING) is specialized in G01. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 13.02.2012 - Priority Date (EP 20120382048)
  • 22.08.2013 - Publication A1 (WO2013120830)
  • 24.12.2014 - Publication A1 (EP2815240)
  • 27.07.2016 - Publication B1 (EP2815240)

IPC Classification